Lilly To Capitalize On Rx, Diagnostic Synergies Via MedTech Venture Fund
This article was originally published in The Gray Sheet
Executive Summary
Eli Lilly's MedTech Venture Fund plans to support companies developing molecular diagnostics and imaging to aid in drug discovery development